HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook

Key Points

• Exchange-related pressure is weighing on HCA’s 2026 outlook: The expiration of enhanced tax credits is pushing some patients into uninsured status, with estimated full-year impact of $1 billion to $1.2 billion and slower elective-care utilization.
• State supplemental payments and underlying demand provide offsets: HCA expects a $300 million to $500 million net benefit from state programs, while insured business excluding exchange plans grew 3.2% and adjusted admissions increased 2.7% in the second quarter.
• HCA is pursuing long-term growth through capacity and efficiency investments: The company is expanding outpatient facilities, improving patient throughput and cost management, and maintaining a target of 4% to 6% long-term revenue growth with stable margins.

HCA Healthcare NYSE: HCA CFO Mike Marks said the hospital operator is navigating a changing policy environment in 2026 while continuing to see solid underlying demand for services outside of the health insurance exchanges.

Speaking at an investor conference, Marks described the expiration of enhanced exchange tax credits as the largest near-term issue for HCA and the broader hospital sector. He said some individuals losing exchange coverage are becoming uninsured, creating pressure on payer mix and elective-care utilization.

Still, Marks said demand in HCA’s markets remains favorable. In the second quarter, insured business excluding exchange plans rose 3.2% from a year earlier. The company reported 2.5% admission growth and 2.7% adjusted-admissions growth during the period.

Exchange impact and state payment programs

Based on developments during the first half of the year, HCA updated its estimated full-year exchange-related impact to between $1 billion and $1.2 billion, Marks said. He said the company based that range on its experience through the first six months and its estimates for the remainder of 2026.

Marks noted that comparisons may become somewhat more favorable in the fourth quarter because exchange volumes had already begun slowing in late 2025. He said fourth-quarter 2025 exchange volumes declined by approximately 5,000 equivalent admissions from the third quarter, while the full year had recorded exchange growth of more than 10% versus 2024.

Offsetting some of the exchange headwinds, HCA expects state supplemental payments to provide a net benefit of $300 million to $500 million for the year. Marks said five states in which HCA operates were able to advance programs under grandfathering provisions in the One Big Beautiful Bill. All five have moved through approval processes, according to Marks, including Florida, Georgia, Virginia and Colorado.

Marks declined to quantify the impact of Virginia’s State Directed Payment program specifically, but said HCA’s overall estimate for supplemental-payment benefits continues to include Virginia.

Elective surgery pressures

Marks said the primary cause of slower elective surgery volume was the migration of patients from exchange coverage to uninsured status, which can reduce access to elective care. He identified two additional factors affecting surgical trends.

• The ongoing phaseout of Medicare’s Inpatient-Only List is shifting some procedures to outpatient settings. Marks said orthopedics and spine procedures were particularly affected during the second year of the three-year phaseout.
• HCA believes some consumers may be deferring elective procedures because of economic conditions, inflation, energy costs and other household expenses. Marks characterized this as an early hypothesis and the least significant of the three factors he cited.

HCA operates approximately 150 ambulatory surgery centers across its markets. Marks said those facilities support the company’s hospital-centered network strategy and provide a site of care when procedures transition from inpatient to outpatient settings.

He said the company continues to target long-term equivalent-admission growth of 2% to 3%, supported by capital investment, acquisitions and network optimization across 43 markets in 19 states. HCA’s markets, primarily located in the Southeast and Southwest, generally have above-average population growth, stronger economic performance and higher employer-sponsored insurance coverage, Marks said.

Capital investment and operating efficiency

HCA has averaged roughly 600 bed additions annually in recent years, Marks said. The company’s occupancy rate remains in the low- to mid-70% range, and management is balancing bed expansion with efforts to improve patient throughput and reduce length of stay.

Marks said improving length of stay is “the cheapest way to add capital capacity” because it can increase available capacity without requiring additional capital spending. HCA is also investing in operating rooms, emergency department capacity, service lines and outpatient facilities.

The company has increased its outpatient footprint from an average of 12 outpatient facilities per hospital at its 2023 investor day to more than 14 currently. Marks said HCA’s longer-term goal is to reach about 20 outpatient facilities per hospital by the end of the decade.

Cost discipline remains another component of HCA’s outlook. Marks said the company’s resiliency plan generated favorable cost-management results in the second quarter and is expected to contribute more meaningfully in the second half. The program focuses on revenue integrity, asset utilization, variable costs and fixed costs.

HCA has also invested in technology, processes and staffing to address claim denials and underpayments. Marks said the company is working with several large payer partners on digital data exchange and reducing administrative friction in the claims process.

Long-term outlook

Looking beyond the current reform cycle, Marks said HCA expects to manage additional exchange-related pressure in 2027, though he does not expect it to be as severe as in 2026. The company also expects to navigate Medicaid work requirements scheduled to begin in January 2027.

Marks reiterated HCA’s longer-term framework of 4% to 6% top-line revenue growth and at least stable margins, which would support a similar range of EBITDA growth. He said the company’s capital allocation strategy, including share repurchases, could further support earnings-per-share growth.

He identified digital transformation, workforce development, network expansion and financial resiliency as central priorities for the next five years.

About HCA Healthcare (NYSE:HCA)

HCA Healthcare, Inc NYSE: HCA is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.